The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans

Acta Physiologica

Volumn 197, Issue 2, 2009, Pages 151-159

  Sakuma, K ^a   Watanabe, K ^b   Hotta, N ^b   Koike, T ^b   Ishida, K ^b   Katayama, K ^b   Akima, H ^b  

^a TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Foxo; Human; P Akt; Skeletal muscle; Suspension

Indexed keywords

ATROGIN 1; BETA ACTIN; FOLLISTATIN RELATED PROTEIN; MESSENGER RNA; MYOSTATIN; PROTEIN KINASE B; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SERUM RESPONSE FACTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1;

ADULT; ARTICLE; HUMAN; HUMAN EXPERIMENT; LEG; MALE; MEDIATOR; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; MUSCLE MASS; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SUSPENSION; VASTUS LATERALIS MUSCLE;

ADAPTATION, PHYSIOLOGICAL; FORKHEAD TRANSCRIPTION FACTORS; FUNCTIONAL LATERALITY; HUMANS; HYPERTROPHY; IMMOBILIZATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEG; MALE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOSTATIN; REFERENCE VALUES; RNA, MESSENGER; SECOND MESSENGER SYSTEMS; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 69949135816     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.01995.x     Document Type: Article

References (47)

1. Adams, G., Hather, B.M. Dudley, G.A. 1994. Effect of short-term unweighting on human skeletal muscle strength and size. Aviat Space Environ Med 65, 1116 1121.
2. Adams, G.R., Caiozzo, V.J. Baldwin, K.M. 2003. Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol 95, 2185 2201.
3. Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., Panaro, F.J., Na, E., Dharmarajan, K. et al. 2001a. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704 1708.
4. Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J.C., Glass, D.J. Yancopoulos, G.D. 2001b. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3, 1014 1019.
5. Cai, D., Frantz, J.D., Tawa, N.E. Jr., Melendez, P.A., Oh, B.C., Lidov, H.G., Hasselgren, P.O., Frontera, W.R., Lee, J., Glass, D.J. Shoelson, S.E. 2004. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119, 285 298.
6. Carson, J.A. Wei, L. 2000. Integrin signaling's potential for mediating gene expression in hypertrophying skeletal muscle. J Appl Physiol 88, 337 343.
7. Charvet, C., Houbron, C., Parlakian, A., Giordani, J., Lahoute, C., Bertrand, A., Sotiropoulos, A., Renou, L., Schmitt, A., Melki, J., Li, Z., Daegelen, D. Tuil, D. 2006. New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways. Mol Cell Biol 17, 6664 6674.
8. Datta, S.R., Brunet, A. Greenberg, M.E. 1999. Cellular survival; a play in three Akts. Genes Dev 13, 2905 2927.
9. Flück, M., Carson, J.A., Schwartz, R.J. Booth, F.W. 1999. SRF protein is upregulated during stretch-induced hypertrophy of rooster ALD muscle. J Appl Physiol 86, 1793 1799.
10. Gauthier-Rouviére, C., Vandromme, M., Tuil, D., Lautredou, N., Morris, M., Soulez, M., Kahn, A., Fernandez, A. Lamb, N. 1996. Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Mol Biol Cell 7, 719 729.
11. Gordon, S.E., Flück, M. Booth, F.W. 2001. Skeletal muscle focal adhesion kinase, paxillin, and serum response factor are loading dependent. J Appl Physiol 90, 1174 1183.
12. Hill, J.J., Davies, M.V., Pearson, A.A., Wang, J.H., Hewick, R.M., Wolfman, N.M. Qiu, Y. 2002. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277, 40735 40741.
13. Hulmi, J.J., Athtiainen, J.P., Kaasalainen, T., Pollanen, E., Häkkinen, K., Alen, M., Selanne, H., Kovanen, V. Mero, A.A. 2007. Postexercise myostatin and activin IIB mRNA levels; effects of strength training. Med Sci Sports Exerc 39, 289 297.
14. Hulmi, J.J., Kovanen, V., Lisko, I., Selänne, H. Mero, A.A. 2008. The effects of whey protein on myostatin and cell cycle-related gene expression responses to a single heavy resistance exercise bout in trained older men. Eur J Appl Physiol 102, 205 213.
15. Jones, S.W., Hill, R.J., Krasney, P.A., O'Conner, B., Peirce, N. Greenhaff, P.L. 2004. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 18, 1025 1027.
16. Joulia-Ekaza, D. Cabello, G. 2007. The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol 7, 310 315.
17. Kuwahara, K., Barrientos, T., Pipes, G.C., Li, S. Olson, E.N. 2005. Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol Cell Biol 25, 3173 3181.
18. Lange, S., Xiang, F., Yakovenko, A., Vihola, A., Hackman, P., Rostkova, E., Kristensen, J., Brandmeier, B., Franzen, G., Hedberg, B. et al. 2005. The kinase domain of titin controls muscle gene expression and protein turnover. Science 308, 1599 1603.
19. Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S. Kambadur, R. 2002. Myostatin inhibits myoblast differentiation by downregulating MyoD expression. J Biol Chem 277, 49831 49840.
20. Latres, E., Amini, A.R., Amini, A.A., Griffiths, J., Martin, F.J., Wei, Y., Lin, H.C., Yancopoulos, G.D. Glass, D.J. 2005. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280, 2737 2744.
21. Lee, S.J. McPherron, A.C. 2001. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98, 9306 9311.
22. Léger, B., Cartoni, R., Praz, M., Lamon, S., Dériaz, O., Crettenand, A., Gobelet, C., Rohmer, P., Konzelmann, M., Luthi, F. Russell, A.P. 2006. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol (Lond) 57, 923 933.
23. Lynch, G.S. 2001. Therapies for improving muscle function in neuromuscular disorders. Exerc Sport Sci Rev 29, 141 148.
24. Mascher, H., Tannerstedt, J., Elfegoun, T., Ekblom, B.T., Gustafsson, T. Blomstrand, E. 2008. Repeated resistance exercise training induces different changes in mRNA expression of MAFbx and MuRF-1 in human skeletal muscle. Am J Physiol Endocrinol Metab 294, E43 E51.
25. McClung, J.M., Thompson, R.W., Lowe, L.L. Carson, J.A. 2004. RhoA expression during recovery from skeletal muscle disuse. J Appl Physiol 96, 1341 1348.
26. McPherron, A.C. Lee, S.J. 1997b. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94, 12457 12461.
27. McPherron, A.C., Lawler, A.M. Lee, S.J. 1997a. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 38, 783 790.
28. Ogawa, T., Furochi, H., Mameoka, M., Hirasaka, K., Onishi, Y., Suzue, N., Akamatsu, M., Akima, H., Fukunaga, T., Kishi, K., Yasui, N., Ishidoh, K., Fukuoka, H. Nikawa, T. 2006. Ubiquitin ligase gene expression in healthy volunteers with 20-day bedrest. Muscle Nerve 34, 463 469.
29. Rhoads, R.E. 1999. Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 274, 30337 30340.
30. 2+ calmodulin-dependent protein kinase II expression and signalling in skeletal muscle of humans. J Physiol 583 (Pt 2 785 795.
31. Sacheck, J.M., Hyatt, J.P., Raffaello, A., Jagoe, R.T., Roy, R.R., Edgerton, V.R., Lecker, S.H. Goldberg, A.L. 2007. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 21, 140 155.
32. Sakuma, K., Watanabe, K., Sano, M., Uramoto, I. Totsuka, T. 2000. Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles. Biochim Biophys Acta Mol Cell Res 1497, 77 88.
33. Sakuma, K., Nishikawa, J., Nakao, R., Nakano, H., Sano, M. Yasuhara, M. 2003. Serum response factor plays an important role in the mechanically overloaded plantaris muscle of rats. Histochem Cell Biol 119, 149 160.
34. Sakuma, K., Nakao, R., Yamasa, Y. Yasuhara, M. 2006. Normal distribution of presenilin-1 and nicastrin in skeletal muscle and the differential responses of these proteins after denervation. Biochim Biophys Acta Gen Subj 1760, 980 987.
35. Sakuma, K., Akiho, M., Nakashima, H., Akima, H. Yasuhara, M. 2008. Age-related reductions in expression of serum response factor and myocardin-related transcription factor A in mouse skeletal muscles. Biochim Biophys Acta Mol Basis Dis 1782, 453 461.
36. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S.H. Goldberg, A.L. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399 412.
37. Schuelke, M., Wagner, K.R., Stolz, L.E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J.F. Lee, S.J. 2004. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350, 2682 2688.
38. Takano, H., Komuro, I., Oka, T., Shimojima, I., Hiroi, Y., Mizuno, T. Yazaki, Y. 1998. The RhoA family G proteins play a critical role in muscle differentiation. Mol Cell Biol 18, 1580 1589.
39. Tesch, P.A., Trieschmann, J.T. Ekberg, A. 2004. Hypertrophy of chronically unloaded muscle subjected to resistance exercise. J Appl Physiol 96, 1451 1458.
40. Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J. Kambadur, R. 2000. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275, 40235 40243.
41. Tisdale, M.J. 2005. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol 3, 209 217.
42. Vandenburgh, H., Chromiak, J., Shansky, J., Del Tatto, M. Lemaire, J. 1999. Space travel directly induces skeletal muscle atrophy. FASEB J 13, 1031 1038.
43. Wehling, M., Cai, B. Tidball, J.G. 2000. Modulation of myostatin expression during modified muscle use. FASEB J 14, 103 110.
44. Wei, L., Zhou, W., Wang, L. Schwartz, R.J. 2000. β1-Integrin and PI 3-kinase regulate RhoA-dependent activation of skeletal α-actin promoter in myoblasts. Am J Physiol Heart Circ Physiol 278, H1736 H1743.
45. Willoughby, D.S. 2004. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 36, 574 582.
46. Zhu, X., Topouzis, S., Liang, L.F. Stotish, R.L. 2004. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26, 262 272.
47. Zinna, E.M. Yarasheski, K.E. 2003. Exercise treatment to counteract protein wasting of chronic diseases. Curr Opin Clin Nutr Metab Care 6, 87 93.